BioKier Takes a Shot at a New Kind of Diabetes Drug

August 25, 2014 BioKier Takes a Shot at a New Kind of Diabetes Drug: Chapel Hill, NC, drug developer BioKier is beginning human tests of a drug that, if successful, could replace these injection therapies with a pill that coaxes the body to regulate blood sugar levels on its own, says George Szewczyk, BioKier founder and CEO. If it works, BioKier’s approach could offer some advantages over blockbuster diabetes drugs currently available from big pharmaceutical companies.

 

Press Release